South Korea OTC review law approved

IFLR is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

South Korea OTC review law approved

South Korea’s bill that will force banks to seek approval before selling new types of OTC derivatives has passed through the legislation and judiciary committee

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login
Gift this article